预防儿童青少年及年轻成人非法及非医疗用药的干预措施:美国预防服务工作组更新证据报告与系统综述
合并分析未显示干预与非法药物使用有临床重要或统计学显著关联(SMD -0.08,95%CI -0.16至0.001),各研究效应异质性大,健康、社会及法律结局报告稀少且多无组间差异。
要点
- 行为咨询干预预防非法用药的证据不一致且不精确,部分干预显示减少使用,部分无获益或使用增加。
- 26项非妊娠青少年试验的合并结果未显示干预与非法药物使用有显著关联(SMD -0.08,95%CI -0.16至0.001)。
- 仅1项试验报告危害,未发现组间统计学显著差异;健康、社会及法律结局报告稀少。
核心结论
- 行为咨询干预预防青少年及年轻成人非法及非医疗用药的证据不一致且不精确,部分干预与使用减少相关,部分无获益或使用增加。
- 健康、社会及法律结局报告稀少,且多数未显示改善。
研究设计与样本
- 检索MEDLINE、PubMed、PsycINFO和Cochrane对照试验中心注册库,儿童青少年检索2013年1月1日至2019年1月31日,年轻成人(<25岁)检索1992年1月1日至2019年1月31日,监测至2020年3月20日。
- 采用随机效应Meta分析估计干预效应量,由2名研究者独立完成质量评价。
主要发现
- 随访3至32个月时,对照组非法药物使用百分比为2.3%至38.6%,干预组为2.4%至33.7%。
- 组间中位绝对风险差为-2.8%, favoring干预组(范围-11.5%至14.8%)。
- 3项试验对妊娠美洲原住民青年提供围产期家访干预;其中1项试验(n=322)在38个月时发现非法药物使用减少(如过去一个月大麻使用:干预组10.7% vs 对照组15.6%),但更早随访评估未发现减少。
- 19项试验报告健康、社会或法律结局(如精神健康症状、家庭功能、药物使用后果、逮捕),多数显示无组间差异;仅1项试验报告危害,未发现统计学显著组间差异。
临床怎么用
- 当前证据不足以一致支持行为咨询干预可有效预防青少年及年轻成人非法及非医疗用药。
- 临床决策需考虑干预可能无获益或增加使用的可能性,并关注个体化风险评估。
局限性
- 证据不一致且不精确,各研究效应异质性大(I2=57.0%)。
- 健康、社会及法律结局报告稀疏,仅1项试验报告危害。
- 妊娠美洲原住民青年的围产期家访干预仅3项试验,结果有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Illicit and nonmedical (use in ways other than instructed) drug use is common in adolescents and young adults and increases the risk of harmful outcomes such as injuries, violence, and poorer academic performance. OBJECTIVE: To review the benefits and harms of interventions to prevent illicit and nonmedical drug use in children, adolescents, and young adults to inform the US Preventive Services Task Force. DATA SOURCES: MEDLINE, PubMED, PsycINFO, and the Cochrane Central Register of Controlled Trials (January 1, 2013, to January 31, 2019 [children and adolescents]; January 1, 1992, to January 31, 2019 [young adults <25 years]); surveillance through March 20, 2020. STUDY SELECTION: Clinical trials of behavioral counseling interventions to prevent initiation of illicit and nonmedical drug use among young people. DATA EXTRACTION AND SYNTHESIS: Critical appraisal was completed independently by 2 investigators. Data were extracted by 1 reviewer and checked by a second. Random-effects meta-analysis was used to estimate the effect sizes associated with the interventions. MAIN OUTCOMES AND MEASURES: Number of times illicit drugs were used; any illicit drug or any cannabis use. RESULTS: Twenty-nine trials (N = 18 353) met inclusion criteria. Health, social, or legal outcomes such as mental health symptoms, family functioning, consequences of drug use, and arrests were reported in 19 trials and most showed no group differences. The effects on illicit drug use in 26 trials among nonpregnant youth (n = 17 811) were highly variable; the pooled result did not show a clinically important or statistically significant association with illicit drug use (standardized mean difference, -0.08 [95% CI, -0.16 to 0.001]; 24 effects [from 23 studies]; n = 12 801; I2 = 57.0%). The percentage of participants using illicit drugs ranged from 2.3% to 38.6% in the control groups and 2.4% to 33.7% in the intervention groups at 3 to 32 months' follow-up. The median absolute risk difference between groups was -2.8%, favoring the intervention group (range, -11.5% to 14.8%). The remaining 3 trials provided a perinatal home-visiting intervention to pregnant Native American youth. One trial (n=322) found a reduction in illicit drug use at 38 months (eg, cannabis use in the previous month, 10.7% in the intervention group and 15.6% in the control group) but not at earlier follow-up assessments. Across all 29 trials, only 1 trial reported on harms and found no statistically significant group differences. CONCLUSIONS AND RELEVANCE: The evidence for behavioral counseling interventions to prevent initiation of illicit and nonmedical drug use among adolescents and young adults was inconsistent and imprecise, with some interventions associated with reduction in use and others associated with no benefit or increased use. Health, social, and legal outcomes were sparsely reported, and few showed improvements.
引用
- O'Connor E, Thomas R, Senger CA, et al. Interventions to Prevent Illicit and Nonmedical Drug Use in Children, Adolescents, and Young Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2020. PMID: 32453373. doi:10.1001/jama.2020.1432
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。